"Tisch Cancer Institute Receives NCI Cancer Center Designation"
The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has been named a National Cancer Institute cancer center. "The NCI designation recognizes our deep commitment to advance the field of cancer research, treatment, and prevention, and to bring these innovations to cancer patients and their families," TCI Director Steven Burakoff said in a statement. Mount Sinai President and CEO Kenneth Davis noted that among the institute's strengths that were "central to our NCI designation" was TCI's research, based on New York's diverse ethnic communities, into the genetic differences and disparities in care that result in greater cancer risk for some patients. Learn more.
Scientists Create Most Powerful, Accurate Tool Yet to Research Deadliest Blood Cancer
Apr 18, 2023 View All Press Releases
Study Identifies New Gene That Drives Colon Cancer
Oct 14, 2022 View All Press Releases
Molecular Treatment Is Able to Control Brain Metastasis of Different Tumors
Feb 11, 2022 View All Press Releases
Mount Sinai’s Dubin Breast Center Annual Benefit Raises Over $2.5 Million
Feb 08, 2022 View All Press Releases